Clinical trial
Comparing Rates of Dementia and Alzheimer's Disease in Patients Initiating Methotrexate Versus Those Initiating Anti-TNF-α Therapy
NCT04571697 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Rates of Dementia and Alzheimer's Disease in Patients Initiating Methotrexate Versus Those Initiating Anti-TNF-α Therapy
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 28, 2020
- Completion date
- October 27, 2020
- Enrollment
- 34,647 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.